New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 10, 2014
07:03 EDTBDSI, ENDPBioDelivery Sciences announces Buprenorphine study to be locked by Endo Health
The database for the BEMA Buprenorphine Phase 3 clinical study in opioid naive patients with chronic pain is expected to be locked shortly by BDSI's partner, Endo Pharmaceuticals. This event is expected to trigger a $10M milestone payment from Endo per the licensing and development agreement signed in January 2012. In addition, based on recruitment rates in a second Phase 3 clinical study of BEMA Buprenorphine in an opioid experienced patient group, the database for this trial is anticipated to be locked by mid-2014, with results following shortly thereafter.
News For BDSI;ENDP From The Last 14 Days
Check below for free stories on BDSI;ENDP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 14, 2014
09:31 EDTENDPEndo upgraded to Conviction Buy from Buy at Goldman
July 11, 2014
11:19 EDTBDSIOptions with decreasing implied volatility: BDSI CWH INFY MONT
Subscribe for More Information
08:05 EDTENDPEndo recommended ahead of Q2 report at Morgan Stanley
Subscribe for More Information
July 10, 2014
11:01 EDTBDSIOptions with decreasing implied volatility: BDSI
Subscribe for More Information
July 8, 2014
11:25 EDTBDSIOptions with decreasing implied volatility
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use